Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin vs Benzyl Penicillin for Severe Childhood Pneumonia
NCT01399723Phase 3Completed
- Sponsor
- KEMRI-Wellcome Trust Research Programme
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amoxicillin in pneumonia (2 arms), sponsored by KEMRI-Wellcome Trust Research Programme. Primary endpoint: Treatment Failure at 48 Hours (Two Full Days After Enrollment). Started Sep 2011; status: completed.
02
Drugs
amoxicillin
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT01399723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01399723.